Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Nademanee

Showing results (11-20 of 47) with videos related to

Pageof 5
Sort By:
Cancer|August 10, 2000
High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapyA Molina, A Y Krishnan, A Nademanee, et al.
Blood|December 12, 2001
Autologous stem cell transplantation for HIV-associated lymphomaA Krishnan, A Molina, J Zaia, et al.
Human Pathology|June 1, 1992
Immunoarchitecture of normal human bone marrow: a study of frozen and fixed tissue sectionsS S Shin, K Sheibani, J Kezirian, et al.
Blood|November 8, 2001
Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program ExperienceE W Petersdorf, C Kollman, C K Hurley, et al.
Bone Marrow Transplantation|December 18, 2007
Emergency double unrelated umbilical cord blood transplant for acute lymphoblastic leukemia after very late deferral of bone marrow donorC Sarkodee-Adoo, J Alvarnas, A Briggs, et al.
Bone Marrow Transplantation|June 2, 2009
Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilizationM J Dugan, R T Maziarz, W I Bensinger, et al.
Bone Marrow Transplantation|March 9, 2011
Aprepitant (Emend) significantly increases sirolimus levels in patients undergoing allogeneic hematopoietic SCTS Shayani, J M Palmer, T Stiller, et al.
Blood|September 1, 1992
High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: a pilot studyA Nademanee, G M Schmidt, M R O'Donnell, et al.
Cancer Treatment Reports|February 1, 1987
Cytarabine, cisplatin, and etoposide chemotherapy for refractory non-Hodgkin's lymphomaM R O'Donnell, S J Forman, A M Levine, et al.
Blood|March 25, 2000
Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor programP B McGlave, X O Shu, W Wen, et al.
Pageof 5

Showing results (11-20 of 47) with videos related to

Sort By:
Pageof 5
Cancer|August 10, 2000
High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapyA Molina, A Y Krishnan, A Nademanee, et al.
Blood|December 12, 2001
Autologous stem cell transplantation for HIV-associated lymphomaA Krishnan, A Molina, J Zaia, et al.
Human Pathology|June 1, 1992
Immunoarchitecture of normal human bone marrow: a study of frozen and fixed tissue sectionsS S Shin, K Sheibani, J Kezirian, et al.
Blood|November 8, 2001
Effect of HLA class II gene disparity on clinical outcome in unrelated donor hematopoietic cell transplantation for chronic myeloid leukemia: the US National Marrow Donor Program ExperienceE W Petersdorf, C Kollman, C K Hurley, et al.
Bone Marrow Transplantation|December 18, 2007
Emergency double unrelated umbilical cord blood transplant for acute lymphoblastic leukemia after very late deferral of bone marrow donorC Sarkodee-Adoo, J Alvarnas, A Briggs, et al.
Bone Marrow Transplantation|June 2, 2009
Safety and preliminary efficacy of plerixafor (Mozobil) in combination with chemotherapy and G-CSF: an open-label, multicenter, exploratory trial in patients with multiple myeloma and non-Hodgkin's lymphoma undergoing stem cell mobilizationM J Dugan, R T Maziarz, W I Bensinger, et al.
Bone Marrow Transplantation|March 9, 2011
Aprepitant (Emend) significantly increases sirolimus levels in patients undergoing allogeneic hematopoietic SCTS Shayani, J M Palmer, T Stiller, et al.
Blood|September 1, 1992
High-dose chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy during first complete remission in adult patients with poor-risk aggressive lymphoma: a pilot studyA Nademanee, G M Schmidt, M R O'Donnell, et al.
Cancer Treatment Reports|February 1, 1987
Cytarabine, cisplatin, and etoposide chemotherapy for refractory non-Hodgkin's lymphomaM R O'Donnell, S J Forman, A M Levine, et al.
Blood|March 25, 2000
Unrelated donor marrow transplantation for chronic myelogenous leukemia: 9 years' experience of the national marrow donor programP B McGlave, X O Shu, W Wen, et al.
Pageof 5